Free access
Issue
Vet. Res.
Volume 41, Number 2, March–April 2010
Number of page(s) 10
DOI http://dx.doi.org/10.1051/vetres/2009065
Published online 28 October 2009
How to cite this article Vet. Res. (2010) 41:17
References of  Vet. Res. (2010) 41:17
  1. Cattori V., Pepin A.C., Tandon R., Riond B., Meli M.L., Willi B., et al., Real-time PCR investigation of feline leukemia virus proviral and viral RNA loads in leukocytes subsets, Vet. Immunol. Immunopathol. (2008) 123:124–128 [CrossRef] [PubMed].
  2. Essex M., Klein G., Snyder S.P., Harrold J.B., Correlation between humoral antibody and regression of tumours induced by feline sarcoma virus, Nature (1971) 233:195–196 [CrossRef] [PubMed].
  3. Flynn J.N., Hanlon L., Jarrett O., Feline leukaemia virus: protective immunity is mediated by virus-specific cytotoxic T lymphocytes, Immunology (2000) 101:120–125 [CrossRef] [PubMed].
  4. Flynn J.N., Dunham S.P., Watson V., Jarrett O., Longitudinal analysis of feline leukemia virus-specific cytotoxic T lymphocytes: correlation with recovery from infection, J. Virol. (2002) 76:2306–2315 [CrossRef] [PubMed].
  5. Francis D.P., Essex M., Excretion of feline leukaemia virus by naturally infected pet cats, Nature (1977) 269:252–254 [CrossRef] [PubMed].
  6. Gomes-Keller M.A., Gonczi E., Tandon R., Riondato F., Hofmann-Lehmann R., Meli M.L., Lutz H., Detection of feline leukemia virus RNA in saliva from naturally infected cats and correlation of PCR results with those of current diagnostic methods, J. Clin. Microbiol. (2006) 44:916–922 [CrossRef] [PubMed].
  7. Gomes-Keller M.A., Tandon R., Gonczi E., Meli M.L., Hofmann-Lehmann R., Lutz H., Shedding of feline leukemia virus RNA in saliva is a consistent feature in viremic cats, Vet. Microbiol. (2006) 112:11–21 [CrossRef] [PubMed].
  8. Gomes-Keller M.A., Gonczi E., Grenacher B., Tandon R., Hofman-Lehmann R., Lutz H., Fecal shedding of infectious feline leukemia virus and its nucleic acids: a transmission potential, Vet. Microbiol. (2009) 134: 208–217.
  9. Gut M., Leutenegger C.M., Huder J.B., Pedersen N.C., Lutz H., One-tube fluorogenic reverse transcriptionpolymerase chain reaction for the quantitation of feline coronaviruses, J. Virol. Methods (1999) 77:37–46 [CrossRef] [PubMed].
  10. Harbour D.A., Gunn-Moore D.A., Gruffydd-Jones T.J., Caney S.M., Bradshaw J., Jarrett O., Wiseman A., Protection against oronasal challenge with virulent feline leukaemia virus lasts for at least 12 months following a primary course of immunisation with Leukocell 2 vaccine, Vaccine (2002) 20:2866–2872 [CrossRef] [PubMed].
  11. Hardy W.D. Jr, Hess P.W., MacEwen E.G., McClelland A.J., Zuckerman E.E., Essex M., et al., Biology of feline leukemia virus in the natural environment, Cancer Res. (1976) 36:582–588 [PubMed].
  12. Hayes K.A., Rojko J.L., Tarr M.J., Polas P.J., Olsen R.G., Mathes L.E., Atypical localised viral expression in a cat with feline leukaemia, Vet. Rec. (1989) 124:344–346 [PubMed].
  13. Helps C., Lait P., Tasker S., Harbour D., Melting curve analysis of feline calicivirus isolates detected by real-time reverse transcription PCR, J. Virol. Methods (2002) 106:241–244 [CrossRef] [PubMed].
  14. Hofmann-Lehmann R., Huder J.B., Gruber S., Boretti F., Sigrist B., Lutz H., Feline leukaemia provirus load during the course of experimental infection and in naturally infected cats, J. Gen. Virol. (2001) 82:1589–1596 [PubMed].
  15. Hofmann-Lehmann R., Cattori V., Tandon R., Boretti F.S., Meli M.L., Riond B., et al., Vaccination against the feline leukaemia virus: outcome and response categories and long-term follow-up, Vaccine (2007) 25:5531–5539 [CrossRef] [PubMed].
  16. Hofmann-Lehmann R., Cattori V., Tandon R., Boretti F.S., Meli M.L., Riond B., Lutz H., How molecular methods change our views of FeLV infection and vaccination, Vet. Immunol. Immunopathol. (2008) 124:119–123 [CrossRef].
  17. Hoover E.A., Olsen R.G., Hardy W.D. Jr, Schaller J.P., Mathes L.E., Cockerell G.L., Biologic and immunologic response of cats to experimental infection with feline leukemia virus, Bibl. Haematol. (1975) 43:180–183 [PubMed].
  18. Hoover E.A., Mullins J.I., Feline leukemia virus infection and diseases, J. Am. Vet. Med. Assoc. (1991) 199:1287–1297 [PubMed].
  19. Jarrett O., Laird H.M., Hay D., Determinants of the host range of feline leukaemia viruses, J. Gen. Virol. (1973) 20:169–175 [CrossRef] [PubMed].
  20. Jarrett W.F., Crawford E.M., Martin W.B., Davie F., A virus-like particle associated with leukaemia (lymphosarkoma), Nature (1964) 202:567–568 [CrossRef] [PubMed].
  21. Lehmann R., Franchini M., Aubert A.,Wolfensberger C., Cronier J., Lutz H., Vaccination of cats experimentally infected with feline immunodeficiency virus, using a recombinant feline leukemia virus vaccine, J. Am. Vet. Med. Assoc. (1991) 199:1446–1452 [PubMed].
  22. Leutenegger C.M., Hofmann-Lehmann R., Riols C., Liberek M., Worel G., Lups P., et al., Viral infections in free-living populations of the European wildcat, J. Wildl. Dis. (1999) 35:678–686 [PubMed].
  23. Leutenegger C.M., Klein D., Hofmann-Lehmann R., Mislin C., Hummel U., Boni J., et al., Rapid feline immunodeficiency virus provirus quantitation by polymerase chain reaction using the TaqMan fluorogenic real-time detection system, J. Virol. Methods (1999) 78:105–116 [CrossRef] [PubMed].
  24. Levy J., Crawford C., Hartmann K., Hofmann- Lehmann R., Little S., Sundahl E., Thayer V., American Association of Feline Practitioners' feline retrovirus management guidelines, J. Feline Med. Surg. (2008) 10:300–316 [CrossRef] [PubMed].
  25. Lutz H., Pedersen N., Higgins J., Hubscher U., Troy F.A., Theilen G.H., Humoral immune reactivity to feline leukemia virus and associated antigens in cats naturally infected with feline leukemia virus, Cancer Res. (1980) 40:3642–3651 [PubMed].
  26. Lutz H., Pedersen N.C., Durbin R., Theilen G.H., Monoclonal antibodies to three epitopic regions of feline leukemia virus p27 and their use in enzyme-linked immunosorbent assay of p27, J. Immunol. Methods (1983) 56:209–220 [CrossRef] [PubMed].
  27. Lutz H., Pedersen N.C., Theilen G.H., Course of feline leukemia virus infection and its detection by enzyme-linked immunosorbent assay and monoclonal antibodies, Am. J. Vet. Res. (1983) 44:2054–2059 [PubMed].
  28. Lutz H., Arnold P., Hubscher U., Egberink H., Pedersen N., Horzinek M.C., Specificity assessment of feline T-lymphotropic lentivirus serology, Zentralbl. Veterinarmed. B (1988) 35:773–778 [PubMed].
  29. Lutz H., Lehmann R., Winkler G., Kottwitz B., Dittmer A., Wolfensberger C., Arnold P., Feline immunodeficiency virus in Switzerland: clinical aspects and epidemiology in comparison with feline leukemia virus and coronaviruses, Schweiz. Arch. Tierheilkd. (1990) 132:217–225 [PubMed] (in German).
  30. Lutz H.B.S., Corboz L., Müller R., Limacher W., Weber H., Wissler K., Theilen G.H., Combination of polyacrylamide gel electrophoresis with enzyme-linked immunosorbent assay: a simple method for the determination of antibody specifitiy and detection of antigens in complex mixtures, Vet. Immunol. Immunopathol. (1981) 2:425–440 [CrossRef].
  31. Meli M., Kipar A., Muller C., Jenal K., Gonczi E., Borel N., et al., High viral loads despite absence of clinical and pathological findings in cats experimentally infected with feline coronavirus (FCoV) type I and in naturally FCoV-infected cats, J. Feline Med. Surg. (2004) 6:69–81 [CrossRef] [PubMed].
  32. Meli M.L., Cattori V., Martinez F., Lopez G., Vargas A., Simon M.A., et al., Feline leukemia virus and other pathogens as important threats to the survival of the critically endangered Iberian lynx (Lynx pardinus), PLoS ONE (2009) 4:e4744.
  33. Molia S., Chomel B.B., Kasten R.W., Leutenegger C.M., Steele B.R., Marker L., et al., Prevalence of Bartonella infection in wild African lions (Panthera leo) and cheetahs (Acinonyx jubatus), Vet. Microbiol. (2004) 100:31–41 [CrossRef] [PubMed].
  34. Pacitti A.M., Jarrett O., Hay D., Transmission of feline leukaemia virus in the milk of a non-viraemic cat, Vet. Rec. (1986) 118:381–384 [PubMed].
  35. Pedersen N.C., Theilen G., Keane M.A., Fairbanks L., Mason T., Orser B., et al., Studies of naturally transmitted feline leukemia virus infection, Am. J. Vet. Res. (1977) 38:1523–1531 [PubMed].
  36. Rojko J.L., Hoover E.A., Mathes L.E., Hause W.R., Schaller J.P., Olsen R.G., Detection of feline leukemia virus in tissues of cats by a paraffin embedding immunofluorescence procedure, J. Natl. Cancer Inst. (1978) 61:1315–1321 [PubMed].
  37. Rojko J.L., Hoover E.A., Mathes L.E., Olsen R.G., Schaller J.P., Pathogenesis of experimental feline leukemia virus infection, J. Natl. Cancer Inst. (1979) 63:759–768 [PubMed].
  38. Rojko J.L., Kociba G.J., Pathogenesis of infection by the feline leukemia virus, J. Am. Vet. Med. Assoc. (1991) 199:1305–1310 [PubMed].
  39. Tandon R., Cattori V., Gomes-Keller M.A., Meli M.L., Golder M.C., Lutz H., Hofmann-Lehmann R., Quantitation of feline leukaemia virus viral and proviral loads by TaqMan(R) real-time polymerase chain reaction, J. Virol. Methods (2005) 130:124–132 [CrossRef] [PubMed].
  40. Tandon R., Cattori V., Willi B., Meli M.L., Gomes-Keller M.A., Lutz H., Hofmann-Lehmann R., Copy number polymorphism of endogenous feline leukemia virus-like sequences, Mol. Cell. Probes (2007) 21:257–266 [CrossRef] [PubMed].
  41. Tandon R., Cattori V., Pepin A.C., Riond B., Meli M.L., McDonald M., et al., Association between endogenous feline leukemia virus loads and exogenous feline leukemia virus infection in domestic cats, Virus Res. (2008) 135:136–143 [CrossRef] [PubMed].
  42. Torres A.N., Mathiason C.K., Hoover E.A., Re-examination of feline leukemia virus: host relationships using real-time PCR, Virology (2005) 332:272–283 [CrossRef] [PubMed].
  43. Vedbrat S.S., Rasheed S., Lutz H., Gonda M.A., Ruscetti S., Gardner M.B., Prensky W., Feline oncornavirus- associated cell membrane antigen: a viral and not a cellularly coded transformation-specific antigen of cat lymphomas, Virology (1983) 124:445–461 [CrossRef] [PubMed].
  44. Vogtlin A., Fraefel C., Albini S., Leutenegger C.M., Schraner E., Spiess B., et al., Quantification of feline herpesvirus 1 DNA in ocular fluid samples of clinically diseased cats by real-time TaqMan PCR, J. Clin. Microbiol. (2002) 40:519–523 [CrossRef] [PubMed].
  45. Willi B., Boretti F.S., Cattori V., Tasker S., Meli M.L., Reusch C., et al., Identification, molecular characterization, and experimental transmission of a new hemoplasma isolate from a cat with hemolytic anemia in Switzerland, J. Clin. Microbiol. (2005) 43:2581–2585 [CrossRef] [PubMed].